About
BHI Therapeutic Sciences provides access to stem cell therapies for patients seeking options for chronic conditions and injuries. They use autologous stem cells from the patient's own body or rigorously tested umbilical cord donors, avoiding embryonic sources. US board-certified physicians oversee treatments, supported by a Scientific Advisory Board and Ethics Committee to maintain safety standards.
The company focuses on regenerative approaches for conditions like Alzheimer's, strokes, diabetes, arthritis, heart disease, and more than 50 others. They develop disease-specific protocols and collaborate with global institutions and experts. Stem cell therapy aims to regenerate damaged tissue without reliance on medications or surgery.
BHI Therapeutic Sciences advances research with over a decade of work, including publications in peer-reviewed journals and 60 protocols submitted to the US FDA. They emphasize patient safety through Good Tissue Practice and clinical study compliance. Their global partnerships expand access to these measured interventions.
Longevity Contribution
- Uses only autologous or multi-step tested umbilical cord stem cells, never embryonic.
- Overseen by US board-certified physicians and a Scientific Advisory Board for protocol safety.
- Over 10 years of research with the longest perfect safety record and highest potency stem cell doses.
- Developed 60 disease-specific protocols submitted to the US FDA.